» Articles » PMID: 1990552

Should Cyclosporine Be Continued Indefinitely?

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1991 Feb 1
PMID 1990552
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Chemical mutagenesis and high throughput media optimization in MTCC-3538 leads to enhanced production of cyclosporine A.

Abrol V, Kushwaha M, Mallubhotla S, Jaglan S 3 Biotech. 2022; 12(8):158.

PMID: 35814036 PMC: 9256877. DOI: 10.1007/s13205-022-03219-x.


Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

Wiseman L, Faulds D Drugs. 2000; 58(6):1029-42.

PMID: 10651389 DOI: 10.2165/00003495-199958060-00006.


Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Frampton J, Faulds D Pharmacoeconomics. 1993; 4(5):366-95.

PMID: 10146875 DOI: 10.2165/00019053-199304050-00007.


Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.

Fulton B, Markham A Drugs. 1996; 51(2):278-98.

PMID: 8808168 DOI: 10.2165/00003495-199651020-00007.


Kidney transplantation in type 1 (insulin-dependent) diabetic patients. Early glomerulopathy.

Osterby R, Nyberg G, Hedman L, Karlberg I, Persson H, Svalander C Diabetologia. 1991; 34(9):668-74.

PMID: 1955100 DOI: 10.1007/BF00400997.